Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the tre...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JOHNSTON THOMAS HENRY PEARSON JAMES PHILIP BROTCHIE JONATHAN MICHAEL MILNE TODD G |
description | The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013150346A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013150346A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013150346A13</originalsourceid><addsrcrecordid>eNqNy78KwjAQgPEsDqK-w4GDk9AYdQ9qqeAg_TOXaC81WO9KLotvr4MP4PQtv2-qykYQ2ENubQFneoRbSBwFPEeoI7oUqIeri89AwrQSOAZB930cdVCipAFF4IK9QPWmLvIL52ri3SC4-HWmlvmpPhRrHLlFGd0dCVPbVJtMG73LzHZvtflPfQAq0zei</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome</title><source>esp@cenet</source><creator>JOHNSTON THOMAS HENRY ; PEARSON JAMES PHILIP ; BROTCHIE JONATHAN MICHAEL ; MILNE TODD G</creator><creatorcontrib>JOHNSTON THOMAS HENRY ; PEARSON JAMES PHILIP ; BROTCHIE JONATHAN MICHAEL ; MILNE TODD G</creatorcontrib><description>The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&CC=US&NR=2013150346A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&CC=US&NR=2013150346A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHNSTON THOMAS HENRY</creatorcontrib><creatorcontrib>PEARSON JAMES PHILIP</creatorcontrib><creatorcontrib>BROTCHIE JONATHAN MICHAEL</creatorcontrib><creatorcontrib>MILNE TODD G</creatorcontrib><title>Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome</title><description>The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy78KwjAQgPEsDqK-w4GDk9AYdQ9qqeAg_TOXaC81WO9KLotvr4MP4PQtv2-qykYQ2ENubQFneoRbSBwFPEeoI7oUqIeri89AwrQSOAZB930cdVCipAFF4IK9QPWmLvIL52ri3SC4-HWmlvmpPhRrHLlFGd0dCVPbVJtMG73LzHZvtflPfQAq0zei</recordid><startdate>20130613</startdate><enddate>20130613</enddate><creator>JOHNSTON THOMAS HENRY</creator><creator>PEARSON JAMES PHILIP</creator><creator>BROTCHIE JONATHAN MICHAEL</creator><creator>MILNE TODD G</creator><scope>EVB</scope></search><sort><creationdate>20130613</creationdate><title>Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome</title><author>JOHNSTON THOMAS HENRY ; PEARSON JAMES PHILIP ; BROTCHIE JONATHAN MICHAEL ; MILNE TODD G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013150346A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHNSTON THOMAS HENRY</creatorcontrib><creatorcontrib>PEARSON JAMES PHILIP</creatorcontrib><creatorcontrib>BROTCHIE JONATHAN MICHAEL</creatorcontrib><creatorcontrib>MILNE TODD G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHNSTON THOMAS HENRY</au><au>PEARSON JAMES PHILIP</au><au>BROTCHIE JONATHAN MICHAEL</au><au>MILNE TODD G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome</title><date>2013-06-13</date><risdate>2013</risdate><abstract>The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2013150346A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T22%3A35%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHNSTON%20THOMAS%20HENRY&rft.date=2013-06-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013150346A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |